Product

Rifafour

2 clinical trials

1 indication

Indication
Tuberculosis
Clinical trial
A Novel 4-month Pan-TB Regimen Targeting Both Host and Microbe (panTB-HM)
Status: Recruiting, Estimated PCD: 2025-09-30